Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Paclitaxel and Carboplatin in Advanced Ovarian Cancer
NCT02437812Phase 2Unknown
- Sponsor
- Gynecologic Oncology Associates
- Start
- Jan 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in epithelial ovarian carcinoma (EOC), fallopian tube carcinoma (PFTC), primary peritoneal carcinoma (PPC), sponsored by Gynecologic Oncology Associates. Status: unknown.
02
Drugs
metformin
03
Conditions
epithelial ovarian carcinoma (EOC)fallopian tube carcinoma (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT02437812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437812.